Expert Perspectives on Managing Functional Bowel Disorders in Rural Settings
  • CME

In this CME-certified video for primary care, experts discuss how to best communicate with patients to ensure proper diagnosis and optimal treatment strategies for IBS.

Lin Chang, MD
William D. Chey, MD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
Released: December 19, 2019 Expiration: December 18, 2020
Multimedia Expert Perspectives on Managing Functional Bowel Disorders in Rural Settings
This program is divided into short segments which you can review from the Activity landing page. After reviewing all segments, click the Claim Credit button to complete the CME posttest and evaluation.
Part 1: Effective Communication (10 min)
Learn how to communicate about sensitive GI concerns.
Launch Part 1: Effective Communication (10 min)
Part 2: Making the Diagnosis and Next Steps (5 min)
Hear how to diagnose IBS when you don’t have ready access to a gastroenterology specialist.
Launch Part 2: Making the Diagnosis and Next Steps (5 min)
Part 3: Treatment (22 min)
Learn what primary care clinicians need to know about current treatment approaches.
Launch Part 3: Treatment (22 min)
Part 4: Questions and Answers (11 min)
Hear expert answers to selected questions from clinicians like you.
Launch Part 4: Questions and Answers (11 min)

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Utilize Rome criteria to diagnose IBS-D and IBS-C and distinguish IBS-C from CIC
  • Consider evidence-based therapies for patients with IBS who have not responded to conventional dietary and pharmacologic interventions


Provided by the American Gastroenterology Association

American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920

Created in collaboration with
National Rural Health Association Logo
Supported by an educational grant from
Salix Pharmaceuticals

Information on this Educational Activity

Disclosure of Conflicts of Interest

The American Gastroenterological Association requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the AGA policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.


Lin Chang, MD

Professor of Medicine
Vatche and Tamar Manoukian Division of Digestive Diseases
David Geffen School of Medicine at UCLA
Los Angeles, California

Lin Chang, MD, has disclosed that she has received consulting fees from Arena, Ironwood, OrphoMed, and Shire-Takeda; has received fees for non-CME/CE services from Allergen and Shire-Takeda; has received royalties from the Rome Foundation; and has less than 5% ownership interest in MetaMe Health and Modify Health.
William D. Chey, MD

University of Michigan Health System
Nostrant Collegiate Professor of Gastroenterology & Nutrition Sciences
Division of Gastroenterology
Michigan Medicine
Ann Arbor, Michigan

William D. Chey, MD, has disclosed that he has received consulting fees from Allergen, Biomerica, IM Health, Ironwood, Outpost, Phathom, Ritter, Redhill, Salix, and Urovant; holds intellectual property rights/patents from Digital Manometry, My Nutrition Health, and Rectal Expulsion Device; has received funds for research support from Biomerica, Ironwood, Nestle, Salix, Vibrant, Urovant, and Zespri; and has less than 5% ownership in Modify Health and Ritter.


Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.
Kara Nyberg, PhD

Editorial Contributor

Kara Nyberg, PhD, has no relevant conflicts of interest to report.
Tiffany Hensley-McBain, PhD

Clinical Editor

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Gastroenterological Association, Clinical Care Options, and the activity supporter do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the American Gastroenterological Association, Clinical Care Options, and the activity supporter. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians, physician assistants, nurse practitioners, nurses, and other healthcare providers who care for patients with IBS or CIC.


The goal of this activity is to improve rural clinicians’ competence in effectively communicating with patients about sensitive GI concerns; diagnosing IBS-C, IBS-D, and CIC; and developing evidence-based treatment regimens to alleviate symptoms.

Physician Continuing Medical Education

Accreditation Statement

American Gastroenterological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

American Gastroenterological Association designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 19, 2019, through December 18, 2020:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Enter asthma patient characteristics in this online CCO tool and compare your treatment plan with those of 5 experts

Michael E. Wechsler, MD, MMSc
Program Director
Bradley E. Chipps, MDFAAP, FACAAI, FAAAAI, FCCP Nicola Alexander Hanania, MD, MS Linda Rogers, MD person default Eileen Wang, MD, MPH
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: August 5, 2020 Expired: August 4, 2021

Slide from CCO on the importance of vaccinating older adults against shingles, with examples of how to overcome common clinical challenges.

Susan Schrimpf Davis, DO Cynthia J. Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Deborah A. Milito, PharmD, BCGP, FASCP Released: July 31, 2020

From EULAR 2020, new data from RABBIT trial assessing risk of herpes zoster infection among RA patients by class of DMARD, as reported by CCO

Released: July 1, 2020

New from EULAR 2020: risk of JAKi, IL-6i, abatacept vs TNFi discontinuation among patients with rheumatoid arthritis, as reported by Clinical Care Options (CCO)

Released: July 1, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?